Bio-Rad Laboratories Inc (BIO)
325.58
+1.89
(+0.58%)
USD |
NYSE |
Nov 21, 16:00
326.10
+0.52
(+0.16%)
Pre-Market: 08:55
Bio-Rad Laboratories Revenue (Quarterly): 649.73M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 649.73M |
| June 30, 2024 | 638.48M |
| March 31, 2024 | 610.82M |
| December 31, 2023 | 681.18M |
| September 30, 2023 | 632.12M |
| June 30, 2023 | 681.11M |
| March 31, 2023 | 676.84M |
| December 31, 2022 | 730.29M |
| September 30, 2022 | 680.80M |
| June 30, 2022 | 691.10M |
| March 31, 2022 | 700.06M |
| December 31, 2021 | 732.77M |
| September 30, 2021 | 747.05M |
| June 30, 2021 | 715.93M |
| March 31, 2021 | 726.80M |
| December 31, 2020 | 789.84M |
| September 30, 2020 | 647.26M |
| June 30, 2020 | 536.88M |
| March 31, 2020 | 571.64M |
| December 31, 2019 | 624.43M |
| September 30, 2019 | 560.63M |
| June 30, 2019 | 572.62M |
| March 31, 2019 | 553.98M |
| December 31, 2018 | 616.85M |
| September 30, 2018 | 545.14M |
| Date | Value |
|---|---|
| June 30, 2018 | 575.91M |
| March 31, 2018 | 551.52M |
| December 31, 2017 | 621.30M |
| September 30, 2017 | 534.14M |
| June 30, 2017 | 504.67M |
| March 31, 2017 | 500.05M |
| December 31, 2016 | 571.45M |
| September 30, 2016 | 508.74M |
| June 30, 2016 | 516.78M |
| March 31, 2016 | 471.20M |
| December 31, 2015 | 570.56M |
| September 30, 2015 | 469.96M |
| June 30, 2015 | 506.10M |
| March 31, 2015 | 472.82M |
| December 31, 2014 | 598.22M |
| September 30, 2014 | 530.64M |
| June 30, 2014 | 536.83M |
| March 31, 2014 | 509.34M |
| December 31, 2013 | 602.64M |
| September 30, 2013 | 505.07M |
| June 30, 2013 | 525.32M |
| March 31, 2013 | 499.67M |
| December 31, 2012 | 573.84M |
| September 30, 2012 | 498.70M |
| June 30, 2012 | 510.42M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
536.88M
Minimum
Jun 2020
789.84M
Maximum
Dec 2020
673.26M
Average
680.96M
Median
Revenue (Quarterly) Benchmarks
| Agilent Technologies Inc | 1.578B |
| Bruker Corp | 864.40M |
| Azenta Inc | 170.06M |
| Harvard Bioscience Inc | 21.97M |
| Bionano Genomics Inc | 6.073M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 653.17M |
| Total Expenses (Quarterly) | 585.26M |
| EPS Diluted (Quarterly) | 23.34 |
| Enterprise Value | 8.694B |
| Gross Profit Margin (Quarterly) | 54.78% |
| Earnings Yield | -8.39% |
| Operating Earnings Yield | 3.31% |
| Normalized Earnings Yield | 2.897 |